APYX MEDICAL CORPORATION - COMMON STOCK

Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2024 Revenue Results

13 1 2025 08:00:01 提供 Nasdaq GlobeNewswire

Apyx Medical Corporation Submits 510(k) Premarket Notification to the U.S. Food and Drug Administration for the AYON Body Contouring System™

06 1 2025 08:00:00 提供 Nasdaq GlobeNewswire

Apyx Medical Corporation to Participate in the Piper Sandler 36th Annual Healthcare Conference

27 11 2024 08:00:00 提供 Nasdaq GlobeNewswire

Apyx Medical Corporation to Attend 15th Annual Craig-Hallum Alpha Select Conference

12 11 2024 16:05:00 提供 Nasdaq GlobeNewswire

Apyx Medical Corporation Announces $7,000,000 Million Registered Direct Offering

08 11 2024 07:05:00 提供 Nasdaq GlobeNewswire

Apyx Medical Corporation Reports Third Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook and Introduces Full Year 2025 Financial Outlook

08 11 2024 07:00:00 提供 Nasdaq GlobeNewswire

Apyx Medical Corporation to Release Third Quarter Of Fiscal Year 2024 Financial Results on November 8, 2024

25 10 2024 08:00:00 提供 Nasdaq GlobeNewswire